LSAQ / LifeSci Acquisition II Corp - Insider Trading and Ownership Report - SEC Form 3, 4, 5

LifeSci Acquisition II Corp
US ˙ NASDAQ ˙ US53229E1038
DETTE SYMBOL ER IKKE LÆNGERE AKTIVT

Insideraktier40.543.020 shares
Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

N/A

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

N/A

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

LifeSci Acquisition II Corp insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i LSAQ / LifeSci Acquisition II Corp. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2022-11-17 Pellizzari Christine A 5.000 0,8063 250 16,1260 4.032 1 0.7577 -3.842 -95,30

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

LSAQ / LifeSci Acquisition II Corp Insider Trades
Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i LSAQ / LifeSci Acquisition II Corp. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

LSAQ / LifeSci Acquisition II Corp Insider Trades
Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil
Dato
Handle
Dato
Form Insider Ticker Sikkerhedstitel Kode 10b5-1 Direkte Dyrke motion
Pris
Enhed
Pris
Enheder
Ændret
Værdi
Ændret (1K)
Tilbage
Muligheder
Tilbage
Aktier
2024-03-14 2024-03-12 4 THERMO FISHER SCIENTIFIC INC. SNCE Common Stock U - Other I 5,7500 -868.990 -4.997 0
2024-03-14 2024-03-12 4 THERMO FISHER SCIENTIFIC INC. SNCE Common Stock U - Other I 5,7500 -868.990 -4.997 0
2024-03-14 3/A THERMO FISHER SCIENTIFIC INC. SNCE Common Stock I 17.379.797
2024-03-13 2024-03-12 4 Faulkner Robert C. SNCE Common Stock U - Other D 5,7500 -26.791 -154 0
2024-03-13 2024-03-12 4 Redmile Group, LLC See Footnotes SNCE Common Stock U - Other I 5,7500 -1.017.203 -5.849 0
2024-03-12 2024-03-12 4 Forman Darcy SNCE Common Stock D - Sale to Issuer D 5,7500 -24.644 -142 0
2024-03-12 2024-03-12 4 Forman Darcy SNCE Common Stock U - Other D 5,7500 -15.753 -91 0
2024-03-12 2024-03-12 4 Cotliar Jonathan SNCE Common Stock D - Sale to Issuer D 5,7500 -12.864 -74 0
2024-03-12 2024-03-12 4 Cotliar Jonathan SNCE Common Stock U - Other D 5,7500 -41.891 -241 0
2024-03-12 2024-03-12 4 Shipton Michael SNCE Common Stock U - Other D 5,7500 -9.247 -53 0
2024-03-12 2024-03-10 4 Shipton Michael SNCE Common Stock F - Taxes D 5,7300 -3.006 -17 9.247
2024-03-12 2024-03-10 4 Shipton Michael SNCE Common Stock M - Exercise D 8.713 12.253
2024-03-12 2024-03-12 4 von Autenried Paul SNCE Common Stock U - Other D 5,7500 -2.302 -13 0
2024-03-12 2024-03-12 4 Pellizzari Christine A SNCE Common Stock D - Sale to Issuer D 5,7500 -35.115 -202 0
2024-03-12 2024-03-12 4 Pellizzari Christine A SNCE Common Stock U - Other D 5,7500 -14.579 -84 0
2024-03-12 2024-03-12 4 Zaranek Mike SNCE Common Stock D - Sale to Issuer D 5,7500 -22.212 -128 0
2024-03-12 2024-03-12 4 Zaranek Mike SNCE Common Stock U - Other D 5,7500 -9.070 -52 0
2024-03-12 2024-03-12 4 Tiwari Neil SNCE Common Stock U - Other D 5,7500 -2.050 -12 0
2024-03-12 2024-03-12 4 Rollins Emily SNCE Common Stock U - Other D 5,7500 -2.050 -12 0
2024-03-12 2024-03-12 4 Hubbard John W SNCE Common Stock U - Other D 5,7500 -2.050 -12 0
2024-03-12 2024-03-12 4 Coman David SNCE Common Stock D - Sale to Issuer D 5,7500 -30.781 -177 0
2024-03-12 2024-03-12 4 Coman David SNCE Common Stock U - Other D 5,7500 -53.834 -310 0
2023-10-10 2023-10-07 4 Shipton Michael SNCE Common Stock F - Taxes D 0,4085 -29.201 -12 70.799
2023-10-10 2023-10-07 4 Shipton Michael SNCE Common Stock M - Exercise D 100.000 100.000
2023-08-15 2023-08-12 4 Coman David SNCE Common Stock F - Taxes D 0,4400 -144.576 -64 1.692.333
2023-08-15 2023-08-12 4 Coman David SNCE Common Stock M - Exercise D 495.122 1.836.909
2023-08-15 2023-08-12 4 Forman Darcy SNCE Common Stock F - Taxes D 0,4400 -84.380 -37 807.964
2023-08-15 2023-08-12 4 Forman Darcy SNCE Common Stock M - Exercise D 288.972 892.344
2023-08-15 2023-08-12 4 Zaranek Mike SNCE Common Stock F - Taxes D 0,4400 -74.813 -33 625.677
2023-08-15 2023-08-12 4 Zaranek Mike SNCE Common Stock M - Exercise D 256.207 700.490
2023-08-15 2023-08-12 4 Cotliar Jonathan SNCE Common Stock F - Taxes D 0,4400 -79.839 -35 1.095.131
2023-08-15 2023-08-12 4 Cotliar Jonathan SNCE Common Stock M - Exercise D 230.882 1.174.970
2023-08-15 2023-08-12 4 Pellizzari Christine A SNCE Common Stock F - Taxes D 0,4400 -86.577 -38 989.857
2023-08-15 2023-08-12 4 Pellizzari Christine A SNCE Common Stock M - Exercise D 355.549 1.076.434
2023-05-22 2023-05-19 4 Pellizzari Christine A SNCE Common Stock F - Taxes D -5.614 720.885
2023-05-22 2023-05-19 4 Pellizzari Christine A SNCE Common Stock M - Exercise D 16.667 726.499
2023-05-15 2023-05-11 4 Redmile Group, LLC Footnote SNCE Common Stock A - Award I 0,2526 494.853 125 20.344.070
2023-05-15 2023-05-11 4 Faulkner Robert C. SNCE Common Stock A - Award D 0,2526 494.853 125 535.836
2023-05-12 2023-05-11 4 Tiwari Neil SNCE Common Stock M - Exercise D 40.983 40.983
2023-05-12 2023-05-11 4 Hubbard John W SNCE Common Stock M - Exercise D 40.983 40.983
2023-05-12 2023-05-11 4 von Autenried Paul SNCE Common Stock M - Exercise D 46.040 46.040
2023-05-12 2023-05-11 4 Rollins Emily SNCE Common Stock M - Exercise D 40.983 40.983
2023-05-02 2023-04-28 4 Forman Darcy SNCE Common Stock A - Award D 492.916 603.372
2023-05-02 2023-04-28 4 Cotliar Jonathan SNCE Common Stock A - Award D 257.320 944.088
2023-05-02 2023-04-28 4 Coman David SNCE Common Stock A - Award D 615.650 1.341.787
2023-05-02 2023-04-28 4 Zaranek Mike SNCE Common Stock A - Award D 444.283 444.283
2023-05-02 2023-04-28 4 Pellizzari Christine A SNCE Common Stock A - Award D 702.332 709.832
2022-11-17 2022-11-17 4 Pellizzari Christine A SNCE Common Stock P - Purchase D 0,8063 5.000 4 5.000
2022-07-01 2022-06-29 4 Forman Darcy SNCE Common Stock M - Exercise D 0,2800 68.075 19 110.456
2022-06-15 2022-06-13 4 Redmile Group, LLC SNCE Common Stock J - Other I 3,3800 6.472.228 21.876 19.849.217
2022-06-15 2022-06-13 4 Redmile Group, LLC SNCE Common Stock J - Other I 3,3800 -6.472.228 -21.876 19.849.217
2022-05-25 2022-05-23 4 Faulkner Robert C. SNCE Common Stock A - Award D 3,0500 40.983 125 40.983
2022-05-25 2022-05-23 4 Redmile Group, LLC SNCE Common Stock A - Award I 3,0500 40.983 125 19.849.217
2022-05-24 2022-05-23 4 Tiwari Neil SNCE Restricted Stock Units A - Award D 40.983 40.983
2022-05-24 2022-05-23 4 Rollins Emily SNCE Restricted Stock Units A - Award D 40.983 40.983
2022-05-24 2022-05-23 4 Goulburn Adam SNCE Restricted Stock Units A - Award D 40.983 40.983
2022-05-24 2022-05-23 4 Hubbard John W SNCE Restricted Stock Units A - Award D 40.983 40.983
2022-05-24 2022-05-20 4 Pellizzari Christine A SNCE Restricted Stock Units A - Award D 50.000 50.000
2022-04-21 2022-04-20 4 Cotliar Jonathan SNCE Stock Option M - Exercise D 0,40 -56.731 158.844
2022-04-21 2022-04-20 4 Cotliar Jonathan SNCE Stock Option M - Exercise D 0,85 -3.905 0
2022-04-21 2022-04-20 4 Cotliar Jonathan SNCE Common Stock M - Exercise D 0,4000 56.731 23 686.768
2022-04-21 2022-04-20 4 Cotliar Jonathan SNCE Common Stock M - Exercise D 0,8500 3.905 3 630.037
2022-04-06 2022-04-04 4 Goulburn Adam SNCE Common Stock J - Other D 2.481 2.481
2022-04-06 2022-04-04 4 Lux Capital Management, LLC By Lux Ventures IV, L.P. SNCE Common Stock J - Other I -2.914.667 8.743.999
2022-02-25 2021-12-02 4 Cotliar Jonathan SNCE Stock Option M - Exercise D 0,40 -11.345 215.575
2022-02-25 2021-12-02 4 Cotliar Jonathan SNCE Stock Option M - Exercise D 0,85 -977 3.905
2022-02-25 2021-12-02 4 Cotliar Jonathan SNCE Common Stock M - Exercise D 0,4000 11.345 5 626.132
2022-02-25 2021-12-02 4 Cotliar Jonathan SNCE Common Stock M - Exercise D 0,8500 977 1 614.787
2022-02-25 2021-10-28 4 Cotliar Jonathan SNCE Stock Option M - Exercise D 0,40 -68.074 226.920
2022-02-25 2021-10-28 4 Cotliar Jonathan SNCE Common Stock M - Exercise D 0,4000 68.074 27 613.810
2022-02-25 2021-10-25 4 Cotliar Jonathan SNCE Stock Option M - Exercise D 0,85 -5.857 4.882
2022-02-25 2021-10-25 4 Cotliar Jonathan SNCE Stock Option M - Exercise D 0,85 -4.538 0
2022-02-25 2021-10-25 4 Cotliar Jonathan SNCE Common Stock M - Exercise D 0,8500 5.857 5 545.736
2022-02-25 2021-10-25 4 Cotliar Jonathan SNCE Common Stock M - Exercise D 0,8500 4.538 4 539.879
2022-01-11 2022-01-07 4 Cotliar Jonathan SNCE Stock Option A - Award D 11,47 200.549 200.549
2022-01-11 2022-01-07 4 Pellizzari Christine A SNCE Stock Option A - Award D 11,47 238.095 238.095
2022-01-11 2022-01-07 4 Coman David SNCE Stock Option A - Award D 11,47 557.692 557.692
2022-01-11 2022-01-07 4 Zaranek Mike SNCE Stock Option A - Award D 11,47 185.897 185.897
2022-01-11 2022-01-07 4 Forman Darcy SNCE Stock Option A - Award D 11,47 211.538 211.538
2022-01-11 2022-01-07 4 Geffon Steven SNCE Stock Option A - Award D 11,47 211.538 211.538
2021-12-27 3/A Thermo Fisher Scientific Powder US Holdings Corp. SNCE Common Stock I 17.379.797
2021-12-20 3 THERMO FISHER SCIENTIFIC INC. SNCE Common Stock I 17.379.797
2021-11-08 3/A PPD, Inc. SNCE Common Stock D 17.379.797
2021-10-18 3 PPD, Inc. SNCE Common Stock D 17.314.315
2021-10-18 3 Wolfe Josh By Lux Co-Invest Opportunities, L.P. SNCE Common Stock I 3.505.890
2021-10-18 3 Wolfe Josh By Lux Ventures IV, L.P. SNCE Common Stock I 11.658.666
2021-10-18 2021-10-06 4/A Redmile Group, LLC SNCE Common Stock A - Award I 14.808.234 19.808.234
2021-10-15 2021-10-07 4 Tiwari Neil SNCE Stock Option A - Award D 10,05 27.575 27.575
2021-10-12 2021-10-07 4 Rollins Emily SNCE Stock Option A - Award D 10,05 27.575 27.575
2021-10-12 2021-10-07 4 Hubbard John W SNCE Stock Option A - Award D 10,05 27.575 27.575
2021-10-12 2021-10-06 4 Hubbard John W SNCE Earn-Out Right A - Award D 50.802 50.802
2021-10-12 2021-10-07 4 Pellizzari Christine A SNCE Stock Option A - Award D 10,05 247.000 247.000
2021-10-12 2021-10-06 4 Pellizzari Christine A SNCE Earn-Out Right A - Award D 8.541 8.541
2021-10-12 2021-10-07 4/A Coman David SNCE Stock Option A - Award D 10,05 981.437 981.437
2021-10-12 2021-10-06 4/A Coman David SNCE Earn-Out Right A - Award D 577.984 577.984
2021-10-12 2021-10-07 4 Geffon Steven SNCE Stock Option A - Award D 10,05 1.017.351 1.017.351
2021-10-12 2021-10-06 4 Geffon Steven SNCE Earn-Out Right A - Award D 115.079 115.079
2021-10-12 2021-10-07 4/A Zaranek Mike SNCE Stock Option A - Award D 10,05 467.351 467.351
2021-10-12 2021-10-06 4/A Zaranek Mike SNCE Earn-Out Right A - Award D 120.644 120.644
2021-10-12 2021-10-07 4 Goulburn Adam SNCE Stock Option A - Award D 10,05 27.575 27.575
2021-10-12 2021-10-07 4 Forman Darcy SNCE Stock Option A - Award D 10,05 1.020.754 1.020.754
2021-10-12 2021-10-06 4 Forman Darcy SNCE Earn-Out Right A - Award D 50.428 50.428
2021-10-12 2021-10-07 4 Cotliar Jonathan SNCE Stock Option A - Award D 10,05 442.754 442.754
2021-10-12 2021-10-06 4 Cotliar Jonathan SNCE Earn-Out Right A - Award D 107.692 107.692
2021-10-12 2021-10-07 4 Redmile Group, LLC See Footnotes SNCE Stock Option (Right to Buy) A - Award I 10,05 41.363 41.363
2021-10-12 2021-10-07 4 Faulkner Robert C. SNCE Stock Option (Right to Buy) A - Award D 10,05 41.363 41.363
2021-10-08 2021-10-06 4 Hubbard John W SNCE Stock Option A - Award D 0,28 403.896 403.896
2021-10-08 2021-10-06 4 Geffon Steven SNCE Stock Option A - Award D 0,28 914.916 914.916
2021-10-08 2021-10-06 4 Cotliar Jonathan SNCE Stock Option A - Award D 0,40 294.986 294.986
2021-10-08 2021-10-06 4 Cotliar Jonathan SNCE Stock Option A - Award D 0,85 10.739 10.739
2021-10-08 2021-10-06 4 Cotliar Jonathan SNCE Stock Option A - Award D 0,85 4.538 4.538
2021-10-08 2021-10-06 4 Cotliar Jonathan SNCE Common Stock A - Award D 533.264 533.264
2021-10-08 2021-10-06 4 Forman Darcy SNCE Stock Option A - Award D 0,28 136.147 136.147
2021-10-08 2021-10-06 4 Forman Darcy SNCE Stock Option A - Award D 0,82 136.147 136.147
2021-10-08 2021-10-06 4 Forman Darcy SNCE Stock Option A - Award D 0,40 93.602 93.602
2021-10-08 2021-10-06 4 Forman Darcy SNCE Common Stock A - Award D 42.381 42.381
2021-10-08 2021-10-06 4 Zaranek Mike SNCE Stock Option A - Award D 9,06 457.455 457.455
2021-10-08 2021-10-06 4 Zaranek Mike SNCE Stock Option A - Award D 0,28 914.916 914.916
2021-10-08 2021-10-06 4 Zaranek Mike SNCE Common Stock A - Award D 322.783 322.783
2021-10-08 2021-10-06 4 Pellizzari Christine A SNCE Stock Option A - Award D 9,49 1.270.710 1.270.710
2021-10-08 2021-10-06 4 Coman David SNCE Stock Option A - Award D 0,28 3.848.459 3.848.459
2021-10-08 2021-10-06 4 Coman David SNCE Common Stock A - Award D 723.320 723.320
2021-10-08 2021-10-06 4 Redmile Group, LLC SNCE Common Stock A - Award I 14.750.786 19.750.786
2021-10-08 3 Green Jeremy SNCE Common Stock I 5.000.000
2021-08-26 2021-08-25 4 McDonald Andrew I Owned by LifeSci Holdings LLC LSAQ Common Stock J - Other I -138.591 1.772.034
2021-08-26 2021-08-25 4 LifeSci Holdings LLC LSAQ Common Stock J - Other D -138.591 1.772.034
2021-08-26 2021-08-25 4 Rice Michael Yehuda Owned by LifeSci Holdings LLC LSAQ Common Stock J - Other I -138.591 1.772.034
2020-11-25 2020-11-24 4 McDonald Andrew I LSAQ Warrants A - Award I 11,50 0,9000 3.146.453 2.832 3.146.453
2020-11-25 2020-11-24 4 Rice Michael Yehuda LSAQ Warrants A - Award I 11,50 0,9000 3.146.453 2.832 3.146.453
2020-11-25 2020-11-24 4 LifeSci Holdings LLC LSAQ Warrants A - Award D 11,50 0,9000 3.146.453 2.832 3.146.453
2020-11-20 3 Mathers Thomas P. LSAQ Common Stock D 6.000
2020-11-20 3 Janssen Scott LSAQ Common Stock D 6.000
2020-11-20 3 wynn Thomas Joseph III LSAQ Common Stock D 6.000
2020-11-20 3 Graham G. Walmsley LSAQ Common Stock D 6.000
2020-11-20 3 McDonald Andrew I Owned by LifeSci Holdings LLC LSAQ Common Stock I 1.910.625
2020-11-20 3 Rice Michael Yehuda Owned by LifeSci Holdings LLC LSAQ Common Stock I 1.910.625
2020-11-20 3 LifeSci Holdings LLC LSAQ Common Stock D 1.910.625
2020-11-20 3 Barrett Elizabeth A. LSAQ Common Stock D 6.000
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista